This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A clinical trial showed that a nasal spray that patients administer at home, without a physician, successfully and safely treated recurrent episodes of a condition that causes rapid abnormal heartrhythms.
Wearable, long-term continuous heart monitors helped identify 52% more cases of atrial fibrillation compared to usual care, but that did not lead to a reduction in hospitalizations due to stroke, according to a new study.
a medical device company dedicated to advancing ablation treatment for cardiac arrythmias, announced its participation at the HeartRhythm 2024 conference, taking place in person at the Boston Convention & Exhibition Center and virtually, May 16-19, 2024. EDT, in Rhythm Theater #2. Data Driven Pulsed Field Abstracts Shephal K.
These reductions in cost and carbon emissions will help shape conversations around the value of medical technology re-use at the annual HeartRhythm Society conference in Boston. I am hopeful that HeartRhythm Society’s conference will reflect this.” electrophysiology labs.
milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrial fibrillation (AFib).
milla1cf Thu, 05/30/2024 - 10:31 May 30, 2024 — Stereotaxis , a pioneer in surgical robotics for minimally invasive endovascular intervention, announced the successful treatment of the first heartrhythm patients by Penn Presbyterian Medical Center (PPMC) utilizing the advanced Genesis Robotic Magnetic Navigation System.
tim.hodson Mon, 03/03/2025 - 16:26 March 1, 202 One in three people worldwide will develop a potentially life-threatening heartrhythm disorder in their lifetime, yet awareness remains critically low. While some heartrhythm disorders are harmless, others can lead to severe complications.
care pathways and to provide millions of Americans with the ability to just use their smartphone to obtain easy and accurate heartrhythm measurements. These measurements can enable the early detection and monitoring of heartrhythm conditions such as atrial fibrillation. and a specificity of 99.9%.1 business activities.
electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. electrophysiology labs, and will be participating in the HeartRhythm Society annual meeting, HRS 2024, May 16-19 in Boston, MA. Innovative Health, Inc. electrophysiology labs.
In a study published in HeartRhythm, researchers from Brigham and Women's Hospital, a founding member of the Mass General Brigham health care system, analyzed real-world clinical data to measure the impact of evidence-based best-practices on patient outcomes for the most common AF procedure: radiofrequency (RF)-based ablation.
Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment 5. Scientists Suggest a New Method for Diagnosing Heart Diseases 6. Weight Loss Drug Linked with Reduced Need for Diuretics in Heart Failure Patients 7.
milla1cf Fri, 05/17/2024 - 18:54 May 17, 2024 — Royal Philips , a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the HeartRhythm Annual Meeting in Boston (May 16-19).
Two articles and an accompanying editorial in HeartRhythm , the official journal of the HeartRhythm Society, the Cardiac Electrophysiology Society , and the Pediatric & Congenital Electrophysiology Society , published by Elsevier , address the controversy and recommend shortening the blanking period.
of cases, with little variation in the rate of rarely appropriate implants across hospitals, according to a study published in HeartRhythm. ICD and CRT-D implants were considered appropriate in 95% of cases and rarely appropriate in 1.7%
a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced new study data demonstrating that HeartBeam AI combined with vectorcardiography (VCG) outperformed an expert panel of heartrhythm cardiologists in detecting atrial flutter.
The robotic technology represented an entirely novel way to address heartrhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
Higher hospital and physician atrial fibrillation (AFib) ablation procedure volumes were associated with increased acute procedural success and lower rates of major adverse events (MAEs), according to a study published in HeartRhythm.
will have AF, an irregular and potentially dangerous heartrhythm. The data supports the conclusion that the AI-based analytics from the ICMs provide valuable information, particularly for those at a higher risk of an AF-related hospitalization, clinic visit, or therapeutic intervention. By 2030, approximately 12.2 Piccini, M.D.,
Recognizing this imperative, ADN CoE recently organized a comprehensive SVT Ablation Training program at the prestigious 9 Eylül University HeartRhythm Management Centre. Oguzhan Ekrem Turan for their invaluable contributions, inspiring the participants with their wealth of knowledge and clinical acumen.
Background:Most out-of-hospital cardiac arrest (OHCA) patients who are initially treated with an automated external defibrillator (AED) and present in a non-shockable rhythm never receive a shock. Each patient’s heartrhythms were reviewed by an expert. Application of any medication during AED use was unlikely.
5 Catheter ablation is a safe and effective procedure when drugs don't work to help restore the heart's incorrect electrical signals, which causes an abnormal heartrhythm.6 2,3 Approximately 1 in 4 adults over the age of 40 are at risk for developing AFib.4 1 These included one pseudoaneurysm, one PV stenosis and one hematoma.1
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
The data was presented by Vivek Reddy , MD, Director of Cardiac Arrhythmia Services at The Mount Sinai Hospital , during the European HeartRhythm Association (EHRA) conference in Berlin, Germany. This marks the first scientific presentation on the company’s deep learning algorithm, HeartBeam AI. for VCG vs. 71.2%
Cardioversion is used to correct abnormal heartrhythms, also known as arrhythmias. When your heart beats too quickly, too slow, or irregularly, it can affect your blood flow and lead to severe complications like stroke or heart failure. Cardioversions can help “reset” your heartrhythm to its regular pattern.
Computer-generated heart replicas, or twins, can be used to identify hidden abnormalities in patients with a dangerous heartrhythm disorder, according to a study published Jan. 6 in Circulation.
New VAs during AHF have previously identified patients with higher in-hospital and 60-day morbidity and mortality. The characteristics and logistics of pre-hospital emergency medicine, as well as the density of centres capable of treating AHF and VAs, differ massively throughout Europe.
Pittsburgh-based Allegheny Health Network received a $5 million gift from the Mario Lemieux Foundation and Highmark Health, which will support the cardiovascular institute and rename it the Mario Lemieux Center for HeartRhythm Care at AHN.
A research team led by Ida Anna Cappello of the HeartRhythm Management Centre of the University Hospital Brussels (VUB) has made significant strides in the field of biomedical engineering by developing innovative 3D printed surgical guides for cardiovascular procedures.
Atrial fibrillation (AF) is the most common heartrhythm disorder in clinical practice. However, most research in this area has focused on hospital patients. It worsens the quality of life of patients, leads to an increase in the mortality rate because of its association with a high risk of thromboembolic complications.
The Boston Scientific announcement also reported the following: During a traditional ablation procedure, a catheter is guided to the interior of the heart and generates extreme temperatures – hot or cold – to destroy targeted areas associated with abnormal heartrhythms. physicians and patients alike," Reddy added.
He was noted to have irregular heartrhythm with rates 120-170s. CT noncon prelim consistent with pneumonia, final read pending Patient's HR 110s, respiratory effort improved, reported symptomatic improvement Later in afternoon After a brief hospital stay, the patient was discharge, still in atrial fibrillation.
The findings were presented during the final day of the HeartRhythm Society meeting, HRS 2024. have heart failure, and the prevalence is expected to rise to 8.5 1 Additionally, more than 30% of heart failure patients have conduction abnormalities. Approximately 6.7 million adults in the U.S. million by 2030.
In addition to size and longevity benefits, Micra devices are also the only leadless pacemakers with remote monitoring capabilities, which allow a doctor or clinic to check on a patient's heart device without the need for a patient to travel to their clinic for an in-person appointment. HeartRhythm. HeartRhythm.
Consider plugging the monitor at the hospital bedside to eliminate the need for an in-person interrogation and expedite patient discharge. Actionable Step: Prior to the implant, educate patients about remote monitoring. After implant, pair the monitor for the initial transmission.
These leads allowed for assessing different aspects of the heart’s electrical activity from different angles. Advancements continued when the first portable ECG machine was introduced in the 1960s, enabling ECG monitoring outside hospitals and clinics. ECG application has expanded its boundaries beyond traditional cardiology.
It can only suggest that there are some heartrhythm abnormalities in the signal, but it does not indicate where they are, how long they last, or what they really mean in terms of the whole signal. Michael Kühne MD, Head of Clinic Atrial Fibrillation at University Hospital Basel in Switzerland.
The Beginning: The Need for Cardiac Remote Patient Monitoring The first implantable pacemaker, was developed in the late 1950s, but the first clinically successful pacemaker was implanted into a 77-year-old at a Veterans Affairs hospital in New York in 1960.
Since it was announced as a Class 1A recommendation in 2015 by the HeartRhythm Society, cardiac remote patient monitoring has become the standard of care for cardiac device patients. Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heartrhythms.
Atrial fibrillation, or AFib, is the most common type of heartrhythm disorder (arrhythmia), affecting over 6 million Americans, and the number is expected to double by 2030. Catheter ablation is a minimally invasive procedure that disables portions of heart tissue that cause irregular heartrhythms. “In
Reduce Hospital Readmissions Many problems can arise with the heart, which does not necessarily show themselves while the patient is at the hospital. Portable ECG devices are also helpful for people at a higher risk of developing cardiac issues or with a family history of heart disease.
A 50-year-old lady was admitted to my hospital with crushing chest tightness. She had an ECG which suggested changes in keeping with a lack of blood getting to the heart. Troponins are enzymes released from the heart when the heart has been damaged. I’ll try and explain this a bit better by using a case study.
While both devices are designed to capture heartrhythm data, they differ in terms of capabilities and usage. It got its name from Dr. Norman Holter, an American biophysicist who was seeking a solution for recording long-term cardiac activity outside of hospital settings in the late 1940s.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content